{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:25:11Z","timestamp":1791573911040,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006366","name":"Minist\u00e9rio da Educa\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clinbiochem.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T21:07:05Z","timestamp":1655154425000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evaluation of the Tasso-SST\u00ae capillary blood microsampling device for the measurement of endogenous uracil levels"],"prefix":"10.1016","volume":"107","author":[{"given":"Milene","family":"Menestrina Dewes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"C\u00e9 da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Fazenda Meireles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Viana de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Frank Bastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Feltraco Lizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zilles Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Venzon Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-5073","authenticated-orcid":false,"given":"Rafael","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2022.06.003_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bmc.2741","article-title":"LC-MS\/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients","volume":"27","author":"B\u00fcchel","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0010","first-page":"103","article-title":"Severe toxicity related to the 5-fluorouracil\/leucovorin combination (the Mayo Clinic regimen): A prospective study in colorectal cancer patients","volume":"26","author":"Tsalic","year":"2003","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41431-019-0540-0","article-title":"Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene\u2013drug interaction of DPYD and fluoropyrimidines","volume":"28","author":"Lunenburg","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","article-title":"Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil","volume":"40","author":"van Kuilenburg","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/bjc.2017.94","article-title":"Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity","volume":"116","author":"Meulendijks","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0030","unstructured":"European Medicines Agency, EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine, EMA Recomm. DPD Test. Prior to Treat. with Fluorouracil, Capecitabine, Tegafur Flucytosine. 31 (2020) 3. https:\/\/www.ema.europa.eu\/en\/news\/ema-recommendations-dpd-testing-prior-treatment-fluorouracil-capecitabine-tegafur-flucytosine."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0035","unstructured":"Haute Autorit\u00e9 de Sant\u00e9, Recherche de d\u00e9ficit en dihydropyrimidine d\u00e9shydrog\u00e9nase en vue de pr\u00e9venir certaines toxicit\u00e9s s\u00e9v\u00e8res survenant sous traitement comportant des fluoropyrimidines, Recommandations et R\u00e9f\u00e9rentiels. (2018) 101. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2018-12\/recherche_dun_deficit_en_dihydropyrimidine_deshydrogenase_visant_a_prevenir_certaines_toxicites_severes_associees_aux_traite.pdf."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0040","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/chromsci\/bms085","article-title":"Validation of an ultra-high performance liquid chromatography tandem mass spectrometric method for quantifying uracil and 5,6-dihydrouracil in human plasma","volume":"50","author":"Coudor\u00e9","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.clinbiochem.2015.04.019","article-title":"Improved determination of uracil and dihydrouracil in plasma after a loading oral dose of uracil using high-performance liquid chromatography with photodiode array detection and porous graphitic carbon stationary phase","volume":"48","author":"Hahn","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0050","first-page":"98","article-title":"An accurate dihydrouracil\/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practice, J. Chromatogr. B. Analyt. Technol. Biomed","volume":"823","author":"Remaud","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0055","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4155\/bio-2020-0176","article-title":"Patient-centric sampling special focus issue","volume":"12","author":"Spooner","year":"2020","journal-title":"Bioanalysis."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FTD.0000000000000864","article-title":"Alternative Sampling Devices to Collect Dried Blood Microsamples: State-of-the-Art","volume":"43","author":"Delahaye","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0065","unstructured":"Tasso, Tasso SST Device Instructions, (2020) 1\u20135. https:\/\/static1.squarespace.com\/static\/60da6eca05215e687a479088\/t\/60dbd1df58d2911b9d7054d2\/1625018884804\/Tasso-SST_DeviceInstructions.pdf."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0070","unstructured":"EMA - European Medicines Agency, Guideline on bioanalytical method validation, (2011) 1\u201323. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0075","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.chroma.2009.09.052","article-title":"Porous graphitic carbon: A versatile stationary phase for liquid chromatography","volume":"1217","author":"West","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2016.04.039","article-title":"Development and validation of a rapid and sensitive UPLC-MS\/MS method for determination of uracil and dihydrouracil in human plasma","volume":"126","author":"Jacobs","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FTD.0000000000000768","article-title":"Phenotyping of uracil and 5-fluorouracil metabolism using LC-MS\/MS for prevention of toxicity and dose adjustment of fluoropyrimidines","volume":"42","author":"Tafzi","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpba.2017.04.055","article-title":"Development, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5,6-dihydrouracil, 5-fluorouracil, 5,6-dihydro-5-fluorouracil, \u03b1-fluoro-\u03b2-ureidopropionic acid and \u03b1-fluoro-\u03b2-alanine in human plasma","volume":"142","author":"Chavani","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12020231","article-title":"Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States","volume":"12","author":"Dub\u00e9","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.clinbiochem.2022.06.003_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0255841","article-title":"Self-collection of capillary blood using Tasso- SST devices for Anti-SARS-CoV-2 IgG antibody testing","volume":"16","author":"Hendelman","year":"2021","journal-title":"PLoS ONE"},{"issue":"2021","key":"10.1016\/j.clinbiochem.2022.06.003_b0105","first-page":"104","article-title":"Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England","volume":"83","author":"Vusirikala","year":"2020","journal-title":"J. Infect."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:10:19Z","timestamp":1762114219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912022001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":21,"alternative-id":["S0009912022001436"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.06.003","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Tasso-SST\u00ae capillary blood microsampling device for the measurement of endogenous uracil levels","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}